SGLT-2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects

被引：119
|
作者：
Lam, Carolyn S. P. [1 ,2 ,3 ,4 ]
Chandramouli, Chanchal [1 ]
Ahooja, Vineeta [5 ]
Verma, Subodh [6 ,7 ]
机构：
[1] Natl Heart Ctr Singapore, 5 Hosp Dr, Singapore 169609, Singapore
[2] Duke Natl Univ Singapore, Med Sch, Singapore, Singapore
[3] Univ Med Ctr Groningen, Groningen, Netherlands
[4] George Inst Global Hlth, Newtown, Tas, Australia
[5] Heart Hlth Inst, Toronto, ON, Canada
[6] Univ Toronto, Keenan Res Ctr Biomed Sci, Div Cardiac Surg, St Michaels Hosp, Toronto, ON, Canada
[7] Univ Toronto, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON, Canada
来源：
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2019年 / 8卷 / 20期
关键词：
heart failure; SGLT-2; inhibitors; type 2 diabetes mellitus; unmet needs; ASSOCIATION TASK-FORCE; 2013 ACCF/AHA GUIDELINE; NONCARDIAC COMORBIDITIES; CARDIOVASCULAR OUTCOMES; AMERICAN-COLLEGE; DIABETES-MELLITUS; EJECTION FRACTION; NA+/H+-EXCHANGER; CARDIAC FIBROSIS; FOCUSED UPDATE;
D O I：
10.1161/JAHA.119.013389
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：12
相关论文
共 50 条
  • [41] Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease
    Nevola, Riccardo
    Alfano, Maria
    Pafundi, Pia Clara
    Brin, Chiara
    Gragnano, Felice
    Calabro, Paolo
    Adinolfi, Luigi Elio
    Rinaldi, Luca
    Sasso, Ferdinando Carlo
    Caturano, Alfredo
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (03)
  • [42] SGLT-2 inhibitors and dementia
    Tu, Sung-Yun
    Shao, Shih-Chieh
    Loh, Ching-Hui
    Huang, Huei-Kai
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 386
  • [43] Can SGLT-2 inhibitors resolve the heart failure burden of diabetes mellitus - Is it empaglifozin or the class?
    Tschoepe, Diethelm
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (07) : 1075 - 1076
  • [44] SGLT-2 inhibitors and nephroprotection: current evidence and future perspectives
    Piperidou, Alexia
    Loutradis, Charalampos
    Sarafidis, Pantelis
    JOURNAL OF HUMAN HYPERTENSION, 2021, 35 (01) : 12 - 25
  • [45] The effect of SGLT-2 inhibitors on mortality and heart failure in randomised trials versus observational studies
    Krogh, J.
    Hjorthoj, C.
    Kristensen, S. L.
    Selmer, C.
    Haugaard, S. B.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 228 - 228
  • [46] Prescribing patterns of SGLT-2 inhibitors for patients with heart failure: A two-center analysis
    Chakrala, Teja
    Prakash, Roshni O.
    Kim, Justin
    Gao, Hanzhi
    Ghaffar, Umar
    Patel, Jaymin
    Parker, Alex
    Dass, Bhagwan
    AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2023, 28
  • [47] Implementing the treatment of heart failure with SGLT-2 inhibitors and sacubitril-valsartan: does moneymatter?
    Cavallari, Ilaria
    Maddaloni, Ernesto
    Grigioni, Francesco
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (15) : 1670 - 1672
  • [48] When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?
    Sharma, Aditya
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2024, 91 (04) : 208 - 208
  • [49] When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?
    Badwan, Osamah Z.
    Braghieri, Lorenzo
    Skoza, Warren
    Agrawal, Ankit
    Menon, Venu
    Tang, W. H. Wilson
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2024, 91 (01) : 47 - 51
  • [50] SGLT-2 Inhibitors Reduce Heart Failure-Related Hospitalization in Patients Without Diabetes
    Shaughnessy, Allen F.
    AMERICAN FAMILY PHYSICIAN, 2022, 106 (04) : 461 - 462
12345